Support teaching, research, and patient care.
Board certified in Internal Medicine, General Cardiology, Interventional Cardiology, and Heart Failure and Transplantation. Medical Director of Stanford Cardiac Care Unit since 1991. Clinical interests: CHF, advanced structural heart disease (heart muscle, coronary artery, valve, and pericardial), as well as post radiation and chemotherapy induced heart damage.
I. Congestive Heart FailureNew Medical TherapiesPrognostic EvaluationSelection for Cardiac TransplantationII. Screening for Myocardial NecrosisNew ECG Monitoring DevicesNew Serum MarkersIII. Screening for CADPatients Who Have Received Radiation RxDiabetics Being Considered for Renal Transplantation.
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System
in patients with symptomatic severe tricuspid regurgitation who have been determined to be at
an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the
cardiac surgeon with concurrence by the local Heart Team
Stanford is currently not accepting patients for this trial.
For more information, please contact SPECTRUM, .
View full details